The Munich Startup Alfadocs has completed an expanded Series A financing round of €3.7 million. In addition to existing investors Bayern Kapital and BayBG, three international industry experts are participating for the first time: Stefan Margolis, Kai Romberg, and Sascha Pfeiffer. The new investors bring extensive experience in healthtech, software-as-a-service (SaaS), and international scaling and will also support Alfadocs on the Board of Directors.
Founded ten years ago, SaaS platform digitizes administrative processes in private medical and dental practices. Core functions include appointment booking, diagnosis documentation, billing, and interfaces to X-ray systems. The cloud-based solution is compatible with common devices and meets stringent data protection and compliance requirements. Alfadocs now employs over 60 people at its locations in Munich, Milan, and Turin.
Focus on the Italian market
The new capital is intended to accelerate growth in the Italian market in particular. Plans include establishing an additional location in another major Italian city. Furthermore, the company intends to further develop its platform's technology.
Specifically, the focus is on AI-based functions for automating clinical processes and new tools for patient empowerment. Patients will be given more control over their entire treatment—the so-called "patient journey." The expansion of the app marketplace, which currently includes over 15 applications, and the expansion of the technical team are also part of the growth strategy.
Investors view the move positively: Alfadocs has a strong product-market fit and addresses key challenges in digital healthcare. The goal is to simplify bureaucratic processes, minimize errors, and increase patient satisfaction. The healthtech company plans to expand its leading role in private healthcare, initially in Italy, and then scale internationally in the medium term.
